Document is current
Any future updates will be listed below
-
Authors
Walter, Bianca
Hirsch, Sophie
Kuhlburger, Laurence
Stahl, Aaron
Schnabel, Leonard
Wisser, Silas
Haeusser, Lara A.
Tsiami, Foteini
Plöger, Sarah
Aghaallaei, Narges
Dick, Advaita M
Skokowa, Julia
Schmees, Christian
Templin, Markus
Schenke-Layland, Katja
Tatagiba, Marcos
Nahnsen, Sven
Merk, Daniel J.
Tabatabai, Ghazaleh http://orcid.org/0000-0002-3542-8782
-
Funding
Funding for this research was provided by:
Universitätsklinikum Tübingen
- License Information
-
More Information
Article History
Received: 7 October 2023
Accepted: 25 February 2024
First Online: 12 March 2024
Declarations
:
: Ethical approval numbers: 610/2020BO and 225/2023 BO2.
: Not applicable.
: Gh.T. has served on advisory boards (Bayer, Boehringer Ingelheim, CureVac Miltenyi Biomedicine, Novocure), as a consultant (Bayer, Boehringer Ingelheim, CureVac), as steering committee member in non-interventional trials (Bayer, Novocure), as a speaker (Novocure, Servier), and financial compensation for all these activities was provided as institutional funding to the University Hospital Tübingen. The other authors do not have anything to disclose.
: Parts of this scientific publication are the subject of (non-published) European patent application EP 23 177 739.2.
